261 Recruiting Acute Myeloid Leukemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Acute Myeloid Leukemia
Related Conditions
Top Recruiting Acute Myeloid Leukemia Studies
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
📍 H Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
📍 Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California
View Study & Checklist ➔A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
📍 Children's Hospital of Central California — Madera, California
View Study & Checklist ➔A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔National Cancer Institute "Cancer Moonshot Biobank"
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
View Study & Checklist ➔IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia
📍 City of Hope National Medical Center /ID# 269273 — Duarte, California
View Study & Checklist ➔Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
📍 City of Hope — Duarte, California
View Study & Checklist ➔BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
📍 University of California, Los Angeles — Los Angeles, California
View Study & Checklist ➔Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
📍 Local Institution - 0011 — Huntsville, Alabama
View Study & Checklist ➔Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
📍 Loma Linda University Cancer Center — Loma Linda, California
View Study & Checklist ➔Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
📍 Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
📍 O'Neal Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test
📍 University of California Irvine — Brisbane, California
View Study & Checklist ➔FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia
📍 Smilow Cancer Hospital Care Center at Greenwich — Greenwich, Connecticut
View Study & Checklist ➔Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
📍 University of Chicago — Chicago, Illinois
View Study & Checklist ➔AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Phase I Study of Q702 With Azacitidine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
📍 University of Illinois at Chicago — Chicago, Illinois
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia
📍 Los Angeles General Medical Center — Los Angeles, California
View Study & Checklist ➔Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Cladribine Venetoclax in Monocytic AML
📍 Universtiy of Colorado Hospital — Aurora, Colorado
View Study & Checklist ➔RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔